Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 Mpro, using molecular docking and dynamics simulation studies
- 1 January 2021
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 890, 173664
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India (BT/BI/04/001/2018)
- Department of Science and Technology, Ministry of Science and Technology, India
- Indian Council of Medical Research
This publication has 37 references indexed in Scilit:
- The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected DiseasesPLOS ONE, 2013
- Development and Optimization of a Novel 384-Well Anti-Malarial Imaging Assay Validated for High-Throughput ScreeningThe American Journal of Tropical Medicine and Hygiene, 2012
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug DesignJournal of Virology, 2008
- An Evolutionarily Conserved Mechanism for MicroRNA-223 Expression Revealed by MicroRNA Gene ProfilingCell, 2007
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main ProteasesPLOS Biology, 2005
- Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS DrugsScience, 2003
- Designing screens: how to make your hits a hitNature Reviews Drug Discovery, 2003
- Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibioticsJournal of Chemical Information and Computer Sciences, 1989